X

Active Pharmaceutical Ingredients

Torrent Pharmaceuticals Ltd Q1FY26 Earnings Results – 20% rise in Profits

Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic…

Solara Active Pharma Sciences Ltd Q1FY26; 12% fall in Revenue

Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading…

Suven Life Sciences Ltd Q4FY25; 50% fall in Revenue

Suven Life Sciences Ltd is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialisation of novel therapeutics for…

Pfizer Ltd Q4FY25; 85% rise in Profits

Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility…

Mankind Pharma Ltd Q4FY25; 11% fall in Profits

Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and…

Lupin Ltd Q4FY25; 112% rise in Profits

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and…

Laurus Labs Ltd Q4FY25; 211% rise in Profits

Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership position in select Active…

Sun Pharmaceutical Industries Ltd Q4FY25; 19% fall in Profits

Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and…

Torrent Pharmaceuticals Ltd Q4FY25; 11% rise in Profits

Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic…

Divis Laboratories Ltd Q4FY25; 23% rise in Profits

  Company Overview: Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients. Financial Results: Divis…